Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of voriconazole vs placebo for prophylaxis of invasive pulmonary aspergillosis in chronically respiratory-compromised, Aspergillus-colonized patients (VOCARE)
2007-001841-16Phase 3Active
- Sponsor
- Melchor Riera Jaume
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in aspergillosis comparing Voriconazole prophylaxis with Placebo (2 arms). Primary endpoint: Progression to invasive pulmonary aspergillosis. Started Nov 2007; status: active.
02
Drugs
voriconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on 2007-001841-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001841-16.